rewirebio.iobenchmarks
Dataset subset

Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)

Sci-Plex single-cell profiles of A549, K562 and MCF7 cells treated with belinostat, dacinostat, givinostat or quisinostat 2HCl at several doses, plus controls, preprocessed as in the GIM benchmark.

Evaluation results

7 evaluations · 41 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: CondOT (PICNN, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.825 Weighted composite score (Equal-weight mean of the three protocol-averaged min-max normalised scores (mean distance, Pearson r, Sinkhorn W2) across the seven Table 2 rows on 12 Sci-Plex highest-dose protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CondOT on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'CondOT', column 'Avg. ŝ / rank', score before the bracket
Configuration: CondOT (PICNN, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
(#3) Rank (Rank of the overall normalised score among the seven Table 2 rows on 12 Sci-Plex highest-dose protocols)
unitless · lower

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CondOT on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'CondOT', column 'Avg. ŝ / rank', bracketed rank
Configuration: CondOT (PICNN, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
7270 Runtime (Mean wall-clock seconds per Sci-Plex highest-dose protocol on one NVIDIA RTX 4090 worker, without any one-time pretraining cost)
second · lower

Uncertainty: SD 585.9

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CondOT on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'CondOT', column 'Time (s) / protocol'
Configuration: CondOT (PICNN, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.801 Min max normalised score (Mean distance (L2 distance between predicted and observed mean expression over the 50 marker genes), negated, then min-max normalised across the seven Table 2 rows within each of 12 Sci-Plex highest-dose protocols and averaged over protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CondOT on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'CondOT', column 'ŝMD ↑'
Configuration: CondOT (PICNN, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.932 Min max normalised score (Pearson correlation between predicted and observed mean expression over the 50 marker genes, min-max normalised across the seven Table 2 rows within each of 12 Sci-Plex highest-dose protocols and averaged over protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CondOT on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'CondOT', column 'ŝr ↑'
Configuration: CondOT (PICNN, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.74 Min max normalised score (Debiased Sinkhorn 2-Wasserstein distance between predicted and observed cell sets (epsilon 0.1), negated, then min-max normalised across the seven Table 2 rows within each of 12 Sci-Plex highest-dose protocols and averaged over protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CondOT on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'CondOT', column 'ŝW2 ↑'
Configuration: GIM (Sci-Plex configuration, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.615 Weighted composite score (Equal-weight mean of the three protocol-averaged min-max normalised scores (mean distance, Pearson r, Sinkhorn W2) across the seven Table 2 rows on 12 Sci-Plex highest-dose protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

GIM on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'GIM', column 'Avg. ŝ / rank', score before the bracket
Configuration: GIM (Sci-Plex configuration, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
(#5) Rank (Rank of the overall normalised score among the seven Table 2 rows on 12 Sci-Plex highest-dose protocols)
unitless · lower

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

GIM on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'GIM', column 'Avg. ŝ / rank', bracketed rank
Configuration: GIM (Sci-Plex configuration, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
4500 Runtime (Mean wall-clock seconds per Sci-Plex highest-dose protocol on one NVIDIA RTX 4090 worker, without any one-time pretraining cost)
second · lower

Uncertainty: SD 116.9

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

GIM on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'GIM', column 'Time (s) / protocol'
Configuration: GIM (Sci-Plex configuration, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.691 Min max normalised score (Mean distance (L2 distance between predicted and observed mean expression over the 50 marker genes), negated, then min-max normalised across the seven Table 2 rows within each of 12 Sci-Plex highest-dose protocols and averaged over protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

GIM on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'GIM', column 'ŝMD ↑'
Configuration: GIM (Sci-Plex configuration, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.861 Min max normalised score (Pearson correlation between predicted and observed mean expression over the 50 marker genes, min-max normalised across the seven Table 2 rows within each of 12 Sci-Plex highest-dose protocols and averaged over protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

GIM on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'GIM', column 'ŝr ↑'
Configuration: GIM (Sci-Plex configuration, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.293 Min max normalised score (Debiased Sinkhorn 2-Wasserstein distance between predicted and observed cell sets (epsilon 0.1), negated, then min-max normalised across the seven Table 2 rows within each of 12 Sci-Plex highest-dose protocols and averaged over protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

GIM on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'GIM', column 'ŝW2 ↑'
Configuration: MLP shift regression (GIM codebase, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.821 Weighted composite score (Equal-weight mean of the three protocol-averaged min-max normalised scores (mean distance, Pearson r, Sinkhorn W2) across the seven Table 2 rows on 12 Sci-Plex highest-dose protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MLP on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'MLP', column 'Avg. ŝ / rank', score before the bracket
Configuration: MLP shift regression (GIM codebase, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
(#4) Rank (Rank of the overall normalised score among the seven Table 2 rows on 12 Sci-Plex highest-dose protocols)
unitless · lower

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MLP on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'MLP', column 'Avg. ŝ / rank', bracketed rank
Configuration: MLP shift regression (GIM codebase, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.82 Runtime (Mean wall-clock seconds per Sci-Plex highest-dose protocol on one NVIDIA RTX 4090 worker, without any one-time pretraining cost)
second · lower

Uncertainty: SD 0.25

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MLP on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'MLP', column 'Time (s) / protocol'
Configuration: MLP shift regression (GIM codebase, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.782 Min max normalised score (Mean distance (L2 distance between predicted and observed mean expression over the 50 marker genes), negated, then min-max normalised across the seven Table 2 rows within each of 12 Sci-Plex highest-dose protocols and averaged over protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MLP on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'MLP', column 'ŝMD ↑'
Configuration: MLP shift regression (GIM codebase, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.922 Min max normalised score (Pearson correlation between predicted and observed mean expression over the 50 marker genes, min-max normalised across the seven Table 2 rows within each of 12 Sci-Plex highest-dose protocols and averaged over protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MLP on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'MLP', column 'ŝr ↑'
Configuration: MLP shift regression (GIM codebase, PerturbPFN Table 2)Protocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.758 Min max normalised score (Debiased Sinkhorn 2-Wasserstein distance between predicted and observed cell sets (epsilon 0.1), negated, then min-max normalised across the seven Table 2 rows within each of 12 Sci-Plex highest-dose protocols and averaged over protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MLP on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'MLP', column 'ŝW2 ↑'
Method: Naive nearest-lower-dose baselineProtocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.601 Weighted composite score (Equal-weight mean of the three protocol-averaged min-max normalised scores (mean distance, Pearson r, Sinkhorn W2) across the seven Table 2 rows on 12 Sci-Plex highest-dose protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Naive on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'Naive', column 'Avg. ŝ / rank', score before the bracket
Method: Naive nearest-lower-dose baselineProtocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
(#6) Rank (Rank of the overall normalised score among the seven Table 2 rows on 12 Sci-Plex highest-dose protocols)
unitless · lower

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Naive on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'Naive', column 'Avg. ŝ / rank', bracketed rank
Method: Naive nearest-lower-dose baselineProtocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.543 Min max normalised score (Mean distance (L2 distance between predicted and observed mean expression over the 50 marker genes), negated, then min-max normalised across the seven Table 2 rows within each of 12 Sci-Plex highest-dose protocols and averaged over protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Naive on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'Naive', column 'ŝMD ↑'
Method: Naive nearest-lower-dose baselineProtocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.629 Min max normalised score (Pearson correlation between predicted and observed mean expression over the 50 marker genes, min-max normalised across the seven Table 2 rows within each of 12 Sci-Plex highest-dose protocols and averaged over protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Naive on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'Naive', column 'ŝr ↑'
Method: Naive nearest-lower-dose baselineProtocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.63 Min max normalised score (Debiased Sinkhorn 2-Wasserstein distance between predicted and observed cell sets (epsilon 0.1), negated, then min-max normalised across the seven Table 2 rows within each of 12 Sci-Plex highest-dose protocols and averaged over protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Naive on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'Naive', column 'ŝW2 ↑'
Method: No change baselineProtocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
0.0233 Weighted composite score (Equal-weight mean of the three protocol-averaged min-max normalised scores (mean distance, Pearson r, Sinkhorn W2) across the seven Table 2 rows on 12 Sci-Plex highest-dose protocols)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Observational on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'Observational', column 'Avg. ŝ / rank', score before the bracket
Method: No change baselineProtocol: Sci-Plex highest-dose holdout with min-max normalised MD, Pearson r and W2 (PerturbPFN Table 2)
Dataset subset: Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
(#7) Rank (Rank of the overall normalised score among the seven Table 2 rows on 12 Sci-Plex highest-dose protocols)
unitless · lower

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Observational on the Sci-Plex highest-dose holdout (PerturbPFN Table 2)

perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 2, row 'Observational', column 'Avg. ŝ / rank', bracketed rank

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-c8bea25e5abb · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Subset and evaluation context

This record describes a particular subset or cohort used in an evaluation. Its results do not describe the full dataset.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

9 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Reuse note
Drawn from the same experiment as the store's two PerturBench Srivatsan20 subsets, lit-cells-networks-20261011-perturbench-v4-data-srivatsan20 and perturbench-dataset-srivatsan20, which are covariate-transfer splits to a held-out cell line over PerturBench's own compound selection. This is a different slice of those measurements: four HDAC inhibitors in three cell lines, GIM preprocessing, 50 marker genes per protocol and a dose holdout. No same_data_as link is recorded, because that relation is for subsets whose data are identical.
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Appendix D.1 and D.2

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.reuse_note

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Source dataset
Sci-Plex, Srivatsan et al. 2020, Science 367(6473):45-51 (reference [20])
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Appendix D.1 and D.2

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_dataset

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Source location
Appendix D.1 and D.2
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Appendix D.1 and D.2

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Split
Per cell line and drug pair (12 protocols): the drug's highest dose is the query; context is the control cells, the drug's lower doses and all available doses of the other three drugs in the same cell line
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Appendix D.1 and D.2

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.split

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Subset scope
Cell lines A549, K562, MCF7; drugs belinostat, dacinostat, givinostat, quisinostat 2HCl; all doses of these drugs and control cells
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Appendix D.1 and D.2

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.subset_scope

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Version
Preprocessed epigenetic-regulation benchmark of Schneider et al. 2025, as used in arXiv:2607.23447v1 Appendix D.1
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Appendix D.1 and D.2

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Description
Sci-Plex single-cell profiles of A549, K562 and MCF7 cells treated with belinostat, dacinostat, givinostat or quisinostat 2HCl at several doses, plus controls, preprocessed as in the GIM benchmark.
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Appendix D.1 and D.2

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Relationship: used in
perturbpfn-20261115-protocol-sciplex-highest-dose-normalised
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Appendix D.1 and D.2

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: links:used_in:perturbpfn-20261115-protocol-sciplex-highest-dose-normalised

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Name
Sci-Plex HDAC-inhibitor subset, 3 cell lines by 4 drugs (GIM preprocessing)
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Appendix D.1 and D.2

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: name

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID perturbpfn-20261115-data-sciplex-hdac-3x4.

Source locator: Appendix D.1 and D.2

Related records

Suggest a correction